1)American Psychiatric Association:Diagnostic and Statistical Manual of Mental Disorders,5th ed(DSM-5). American Psychiatric Publishing, Washington DC, 2013[身体症状症.日本精神神経学会(日本語版用語監修),髙橋三郎,大野裕(監訳):DSM-5精神疾患の診断・統計マニュアル.pp307-310,医学書院,2014]
2)Nemiah JC:A reconsideration of psychological specificity in psychosomatic disorders. Psychother Psychosom 38:39-45, 1982[PMID:7146275]
3)Noyes R Jr., Stuart SP, Watson DB:A reconceptualization of the somatoform disorders. Psychosomatics 49:14-22, 2008[PMID:18212171]
4)Afari N, Ahumada SM, Wright LJ, et al:Psychological trauma and functional somatic syndromes:A systematic review and meta-analysis. Psychosom Med 76:2-11, 2014[PMID:24336429]
5)Creed FH, Davies I, Jackson J, et al:The epidemiology of multiple somatic symptoms. J Psychosom Res 72:311-317, 2012[PMID:22405227]
6)Bi X, Moos RH, Timko C, et al:Family conflict and somatic symptoms over 10 years:A growth mixture model analysis. J Psychosom Res 78:459-465, 2015[PMID:25684248]
7)Lee S, Creed FH, Ma YL, et al:Somatic symptom burden and health anxiety in the population and their correlates. J Psychosom Res 78:71-76, 2015[PMID:25466323]
8)Bass C, Murphy M:Somatoform and personality disorders:Syndromal comorbidity and overlapping developmental pathways. J Psychosom Res 39:403-427, 1995[PMID:7562672]
9)Croicu C, Chwastiak L, Katon W:Approach to the patient with multiple somatic symptoms. Med Clin North Am 98:1079-1095, 2014[PMID:25134874]
10)O'Malley PG, Jackson JL, Santoro J, et al:Antidepressant therapy for unexplained symptoms and symptom syndromes. J Fam Pract 48:980-990, 1999[PMID:10628579]
11)Mercier A, Auger-Aubin I, Lebeau JP, et al:Evidence of prescription of antidepressants for non-psychiatric conditions in primary care:An analysis of guidelines and systematic reviews. BMC Fam Pract 14:55, 2013[PMID:23641784]
12)Huang M, Luo B, Hu J, et al:Combination of citalopram plus paliperidone is better than citalopram alone in the treatment of somatoform disorder:Results of a 6-week randomized study. Int Clin Psychopharmacol 27:151-158, 2012[PMID:22367417]
13)Keeley R, Smith M, Miller J:Somatoform symptoms and treatment nonadherence in depressed family medicine outpatients. Arch Fam Med 9:46-54, 2000[PMID:10664642]
14)Koelen JA, Houtveen JH, Abbass A, et al:Effectiveness of psychotherapy for severe somatoform disorder:Meta-analysis. Br J Psychiatry 204:12-19, 2014[PMID:24385460]
15)Tyrer P, Cooper S, Salkovskis P, et al:Clinical and cost-effectiveness of cognitive behaviour therapy for health anxiety in medical patients:A multicentre randomised controlled trial. Lancet 383:219-225, 2014[PMID:24139977]
16)Malins S, Kai J, Atha C, et al:Cognitive behaviour therapy for long-term frequent attenders in primary care:A feasibility case series and treatment development study. Br J Gen Pract 66:e729-736, 2016[PMID:27432609]
17)Barsky AJ, Ahern DK, Bauer MR, et al:A randomized trial of treatments for high-utilizing somatizing patients. J Gen Intern Med 28:1396-1404, 2013[PMID:23494213]
18)Kashner TM, Rost K, Cohen B, et al:Enhancing the health of somatization disorder patients:Effectiveness of short-term group therapy. Psychosomatics 36:462-470, 1995[PMID:7568654]
19)Petrie KJ, Muller JT, Schirmbeck F, et al:Effect of providing information about normal test results on patients' reassurance:Randomised controlled trial. BMJ 334:352, 2007[PMID:17259186]